Assessing the intracranial metabolic score as a novel prognostic tool in primary CNS lymphoma with end of induction-chemotherapy 18F-FDG PET/CT and PET/MR
Abstract Background The metabolic response of primary central nervous system lymphoma (PCNSL) patients has yet to be evaluated. This study aimed to assess the prognostic value of a novel scoring scale, the intracranial metabolic score (IMS), in PCNSL patients receiving end-of-therapy 18F-FDG PET/CT...
Shranjeno v:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2024-11-01
|
| Serija: | Cancer Imaging |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s40644-024-00798-1 |
| Oznake: |
Brez oznak, prvi označite!
|
